Evidence map›Paper›PMID 36232890›Full record

ArticleInternational journal of molecular sciences2022

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

Yulemi Gonzalez Quesada, Luc DesGroseillers

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yulemi Gonzalez QuesadaDépartement de Biochimie et Médecine Moléculaire, Faculté de Médecine, Université de Montréal, 2900 Édouard Montpetit, Montréal, QC H3T 1J4, Canada.
Luc DesGroseillersDépartement de Biochimie et Médecine Moléculaire, Faculté de Médecine, Université de Montréal, 2900 Édouard Montpetit, Montréal, QC H3T 1J4, Canada.

Funding

CIHR MOP-22979Natural Sciences and Engineering Research Council RGPIN-2019-05027
6 · The paper itself

Abstract

Cancer development is regulated by inflammation. Staufen1 (STAU1) is an RNA-binding protein whose expression level is critical in cancer cells as it is related to cell proliferation or cell death. STAU1 protein levels are downregulated during mitosis due to its degradation by the E3 ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C). In this paper, we map the molecular determinant involved in STAU1 degradation to amino acids 38-50, and by alanine scanning, we shorten the motif to F

Indexed as

InflammationRNA-Binding ProteinsUbiquitin-Protein LigasesAlanineAmino AcidsAnaphase-Promoting Complex-CyclosomeCytoskeletal ProteinsHumansInterferonsAlanineAmino AcidsAnaphase-Promoting Complex-CyclosomeCytoskeletal ProteinsInterferonsRNA-Binding ProteinsSTAU1 protein, humanUbiquitin-Protein LigasesdegronE3 ubiquitin ligaseinflammationprotein degradationStaufen1TRIM25

Identifiers

PMID36232890
PMCPMC9569955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.